Immuneering (IMRX) Assets Average (2021 - 2024)
Immuneering (IMRX) has 4 years of Assets Average data on record, last reported at $72.8 million in Q3 2024.
- For Q3 2024, Assets Average fell 39.0% year-over-year to $72.8 million; the TTM value through Sep 2024 reached $72.8 million, down 39.0%, while the annual FY2023 figure was $112.5 million, 22.18% down from the prior year.
- Assets Average reached $72.8 million in Q3 2024 per IMRX's latest filing, down from $82.5 million in the prior quarter.
- Across five years, Assets Average topped out at $165.4 million in Q4 2021 and bottomed at $72.8 million in Q3 2024.
- Average Assets Average over 4 years is $119.7 million, with a median of $116.3 million recorded in 2023.
- Peak YoY movement for Assets Average: increased 27.02% in 2022, then tumbled 39.0% in 2024.
- A 4-year view of Assets Average shows it stood at $165.4 million in 2021, then decreased by 22.58% to $128.0 million in 2022, then dropped by 15.46% to $108.2 million in 2023, then plummeted by 32.72% to $72.8 million in 2024.
- Per Business Quant database, its latest 3 readings for Assets Average were $72.8 million in Q3 2024, $82.5 million in Q2 2024, and $95.3 million in Q1 2024.